Gilead Sciences (GILD) Tax Rate Growth (1y) (2010 - 2026)

Gilead Sciences (GILD) Tax Rate Growth (1y) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn
10 Novartis Ag 112.59 Bn 111.90 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 141.00
Dec 31, 2025 -3,942.00
Sep 30, 2025 4,724.00
Jun 30, 2025 -207.00
Mar 31, 2025 1,323.00
Dec 31, 2024 343.00
Sep 30, 2024 -3,737.00
Jun 30, 2024 -1,324.00
Mar 31, 2024 -1,729.00
Dec 31, 2023 -526.00
Sep 30, 2023 -2,026.00
Jun 30, 2023 1,009.00
Mar 31, 2023 -8,359.00
Dec 31, 2022 -3,086.00
Sep 30, 2022 178.00
Jun 30, 2022 797.00
Mar 31, 2022 8,395.00
Dec 31, 2021 3,558.00
Sep 30, 2021 -3,243.00
Jun 30, 2021 2,906.00